Medical Health & Life Science Research News

Prenatal and new born genetic testing: a general outline of the global market and growth factors scrutinized in new research

Genetic testing is defined as a systematically executed diagnostic and screening technique that is employed for detecting a genetic disorder risk among multicellular or unicellular organisms. This technique typically comprises certain biochemical tests that help detect the presence of a genetic disease or mutant gene forms that could increase the risk of genetic disorders developing in an organism.

Browse Full Report Prenatal and New-born Genetic Testing Market Research Report With Full TOC @ www.transparencymarketresearch.com…etic-testing.html Make an Inquiry about this news   There are several classifications of the technique of genetic testing. These include: diagnostic testing, carrier testing, newborn screening, pre-implementation testing, prenatal testing, forensic and predictive testing.   

The market for prenatal and newborn genetic testing can be segment based on geography and technology.    Speaking specifically of prenatal and newborn genetic testing, these techniques comprise the usage of screening and/or diagnostic procedures that are carried out on a fetus or newborn baby so as to detect abnormalities at the chromosomal level.

These abnormalities could include: Down syndrome, Edward syndrome, or Patau syndrome. By using these testing procedures, it is possible to detect certain types of genetic abnormalities within just eight to ten weeks of conception.

Such screening techniques can also be used for determining the sex of the fetus.    The Northwestern Medical Faculty Foundation states that nearly 85% of all pregnant women are advised to undergo screening/testing for birth defects such as trisomy 18 and open neural tube defects.  

In addition, there are a number of other tests that are beneficial in providing information about trisomy 13 as well as other chromosome abnormalities that may prevail in a fetus or a newborn baby. While many people use the terms diagnostic testing and screening tests interchangeably, there is a difference between these two terms.

For one, both of these procedures are types of genetic tests that can be performed at the prenatal stage and on newborns. While diagnostic tests are used for confirming the presence of certain types of genetic conditions in a newborn baby or at the fetal stage, screening tests are carried out in order to detect the chance of the fetus or newborn baby developing certain genetic abnormalities.   

What are the factors propelling the prenatal and newborn genetic testing market?   Among the most prominent factors that have led to an increased demand for prenatal and newborn genetic testing are: an increasing maternal age and late pregnancies (meaning, women are having babies later in life as compared with their earlier counterparts), advancements in screening and diagnostic technologies, and a rising awareness pertaining to genetic disorders that can affect the fetus.    However, while the awareness is higher than ever before, market analysts still feel that these markets are at a nascent stage, and there is immense scope for growth.

Hence, there are several opportunities-especially in developing countries-that market players can capitalize on. These opportunities abound in markets such as Asia-Pacific, Latin America as well as Africa.  

An overview of the various segments under the prenatal and newborn genetic testing market   In the market that is comprised of diagnostic techniques, the largest segment is constituted of polymerase chain reaction (PCR). The share of PCR is higher as compared to other techniques such as FISH and aCGH.

The market for PCR is largely propelled by the increasing incidences of genetic diseases. However, the use of forensic techniques that boast high process efficiency offer a much higher rate of reliability and precision.   

In the screening methods market, the largest share is currently occupied by the non-invasive prenatal testing (NIPT) segment. This segment is likely to show the highest compounded annual growth rate (CAGR) of 37.6% between 2013 and 2019.  

From the geographical standpoint, the largest market share was occupied by the North American region within the market for prenatal and newborn genetic testing.    Looking forward, the market for prenatal and newborn genetic testing is projected to be worth USD 8.37 billion by the end of 2019, growing at a compounded annual growth rate (CAGR) of 26.9%.  

Get Free Sample Report:- www.transparencymarketresearch.com…B&rep_id=1744 Make an Inquiry about this news  

For more information:

Make an Inquiry about this report HERE!
  • www.transparencymarketresearch.com/prenatal-new-born-genetic…
  • www.transparencymarketresearch.com/sample/sample.php?flag=B&…
  • www.transparencymarketresearch.com

News From

Transparency Market Research - In-depth AnalysisTransparency Market Research
Category: Market Research Publishers and RetailersCompany about: TMR provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business And market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements.      We specialize in the following areas:   Syndicated Research Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverage ...
This email address is being protected from spambots. You need JavaScript enabled to view it.